Austar Lifesciences Limited (HKG:6118)
Hong Kong · Delayed Price · Currency is HKD 0.7300
-0.0500 (-6.41%)
At close: Mar 4, 2026
Austar Lifesciences Market Cap
Austar Lifesciences has a market cap or net worth of 374.18 million as of March 4, 2026. Its market cap has increased by 23.73% in one year.
Market Cap
374.18M
Enterprise Value
585.13M
Revenue
1.60B
Ranking
n/a
PE Ratio
9.70
Stock Price
0.73
Market Cap Chart
Since November 7, 2014, Austar Lifesciences's market cap has decreased from 1.79B to 374.18M, a decrease of -79.04%. That is a compound annual growth rate of -12.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 374.18M | -16.09% |
| Dec 31, 2025 | 445.95M | 52.63% |
| Dec 31, 2024 | 292.17M | -63.46% |
| Dec 29, 2023 | 799.63M | -22.77% |
| Dec 30, 2022 | 1.04B | -86.60% |
| Dec 31, 2021 | 7.73B | 147.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MicroTech Medical (Hangzhou) | 3.07B |
| Sisram Medical | 1.73B |
| Shanghai HeartCare Medical Technology Corporation | 1.57B |
| Cryofocus Medtech (Shanghai) | 1.39B |
| Venus Medtech (Hangzhou) | 1.03B |
| Gaush Meditech | 887.94M |
| Broncus Holding | 722.10M |
| Vincent Medical Holdings | 646.08M |